Carmen Alerany
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Value Contribution of Palopegteriparatide in Adult Patients with Chronic Hypoparathyroidism using Multicriteria Decision Analysis (MCDA).
Journal: Advances in therapy
Published: July 08, 2025
Identification of strengths and weaknesses of the healthcare system for persons living with rare diseases in Catalonia (Spain), and recommendations to improve its comprehensive attention: the "acERca las enfermedades raras" project.
Journal: Orphanet journal of rare diseases
Published: June 30, 2024
Determining value in the treatment of activated PI3Kδ syndrome in Spain: a multicriteria decision analysis from the perspective of key stakeholders.
Journal: Global & regional health technology assessment
Published: February 07, 2024
Value contribution of leniolisib in the Treatment of Activated PI3Kδ syndrome (APDS) in Spain using Multi-Criteria Decision Analysis (MCDA).
Journal: Global & regional health technology assessment
Published: January 02, 2024
Off-Label Use of Rituximab in Patients with Different Types of Nephropathies in a Tertiary Hospital: A Retrospective Study.
Journal: Journal of clinical medicine
Published: September 17, 2021
Outcomes of off-label drug uses in hospitals: a multicentric prospective study.
Journal: European journal of clinical pharmacology
Published: June 11, 2014
Available evidence and outcome of off-label use of rituximab in clinical practice.
Journal: European journal of clinical pharmacology
Published: February 13, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026